WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010149230) NOVEL PHARMACEUTICAL COMPOSITION COMPRISING POLY (ALLYLAMIN-CO-N,N'-DIALLYL- 1,3-DIAMINO-2-HYDROXYPROPANE) HYDROCHLORIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/149230    International Application No.:    PCT/EP2009/058122
Publication Date: 29.12.2010 International Filing Date: 29.06.2009
IPC:
A61K 9/20 (2006.01), A61K 31/785 (2006.01)
Applicants: COMBINO PHARM, S.L. [ES/ES]; Fructuós Gelabert, 6-8 E-08970 Sant Joan Despí (ES) (For All Designated States Except US).
LLORET PÉREZ, Sergio [ES/ES]; (ES) (For US Only).
DÍAZ GUASCH, Laura [ES/ES]; (ES) (For US Only)
Inventors: LLORET PÉREZ, Sergio; (ES).
DÍAZ GUASCH, Laura; (ES)
Agent: ILLESCAS TABOADA, Manuel; C/ Recoletos, 13 5ºIzda 28001 Madrid (ES)
Priority Data:
P200930368 26.06.2009 ES
Title (EN) NOVEL PHARMACEUTICAL COMPOSITION COMPRISING POLY (ALLYLAMIN-CO-N,N'-DIALLYL- 1,3-DIAMINO-2-HYDROXYPROPANE) HYDROCHLORIDE
(FR) NOUVELLE COMPOSITION PHARMACEUTIQUE COMPRENANT DU CHLORHYDRATE DE POLY(ALLYLAMINE-CO-N,N'-DIALLYL-1,3-DIAMINO-2-HYDROXYPROPANE)
Abstract: front page image
(EN)Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3- diamino-2-hydroxypropane) hydrochloride. The invention solves the problem related to the high hygroscopicity of active principle sevelamer hydrochloride, which becomes even more serious if the formulation contains it at high concentrations, particularly if said formulation is a tablet. For solving this problem the formulations of the invention comprise an excipient pharmaceutically acceptable which acts as diluent, preferably a pregelatinized starch.
(FR)L'invention porte sur une nouvelle composition pharmaceutique comprenant du chlorhydrate de poly(allylamine-co-N,N'-diallyl-1,3-diamino-2-hydroxypropane). L'invention résout le problème lié au caractère hygroscope élevé du principe actif chlorhydrate de sevelamer, qui devient encore plus important si la formulation le contient à des concentrations élevées, en particulier si ladite formulation est un comprimé. Pour résoudre ce problème les formulations de l'invention comprennent un excipient pharmaceutiquement acceptable qui sert de diluant, de préférence un amidon prégélatinisé.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)